Healthcare Services

Onychomycosis Treatment Global Forecast: Market to Scale Up to $5.51 Billion by 2030 at 7.3% CAGR

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the onychomycosis treatment market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Onychomycosis Treatment Market in 2026, and what figure is it projected to hit by 2030?

The onychomycosis treatment market size has experienced significant growth over the past few years. It is projected to expand from $3.91 billion in 2025 to $4.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.5%. This historical growth can be attributed to several factors, including the widespread occurrence of onychomycosis, the constrained availability of advanced antifungal medications, an escalating understanding of nail hygiene, a heightened demand for topical antifungal therapies, and the increasing incidence of fungal infections among the elderly population.

The onychomycosis treatment market is projected to experience robust expansion in the coming years, with its size expected to reach $5.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period is attributable to continuous advancements in laser and photodynamic therapy technologies, a rising inclination towards combination treatment methods, an increase in telemedicine consultations specifically for dermatology, the widening distribution networks of hospitals and retail pharmacies, and accelerated research and development focusing on drug-resistant fungal strains. Key trends identified for this period include the increasing uptake of combined drug and laser therapies, a growing application of photodynamic therapy for recalcitrant infections, enhanced awareness regarding preventive nail care, the expanding implementation of AI-based diagnostic tools for fungal infections, and a significant rise in telemedicine adoption for onychomycosis treatment.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12941&type=smp

Which Drivers Are Affecting Market Participation In The Onychomycosis Treatment Market?

A rising incidence of fungal infections is anticipated to boost the expansion of the onychomycosis treatment market going forward. Fungal infections are microbial ailments caused by various fungi, impacting different body parts or leading to specific conditions. Onychomycosis, a fungal nail infection, is commonly managed with oral antifungal medications or topical antifungal solutions to eliminate the underlying fungal growth and promote healthy nail development. For instance, in May 2025, the UK Health Security Agency, a UK-based government agency, indicated that in 2024, the rate of bloodstream infections due to yeasts across England had risen by 31% since 2015 and by 4% from 2023. Furthermore, between 2023 and 2024, there was a 4% increase in the number of laboratory reports of fungemia due to yeasts (from 2,170 to 2,247 reports) in England. Therefore, the growing number of fungal infections is a key driver for the onychomycosis treatment market’s growth.

What Segment Categories Are Covered In The Onychomycosis Treatment Market?

The onychomycosis treatment market covered in this report is segmented –

1) By Type: Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candida Onychomycosis, Other Types

2) By Treatment Type: Drugs, Laser Therapy, Photodynamic Therapy

3) By Age Group: 0 To 18 Years, 18 To 39 Years, 40 To 64 Years, 65 Years And Above

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

What Trends Are Projected To Support The Growth Of The Onychomycosis Treatment Market?

Major companies active in the onychomycosis treatment market are concentrating on developing new products, such as MOB-015, and obtaining approval from federal agencies to secure a competitive advantage. For instance, in June 2023, Moberg Pharma AB, a pharmaceutical company from Sweden, received approval for MOB-015 in the European Union, designated for the treatment of mild to moderate fungal nail infections in adults. This approval from the European Union signifies the innovative onychomycosis medication’s first global marketing authorization. Two Phase 3 trials that supported MOB-015’s approval demonstrated an enhanced mycological cure (76% versus up to 42% for comparators) and a considerably greater total cure rate than the vehicle, all without any serious adverse effects. The topical terbinafine formulation MOB-015 allows effective terbinafine concentrations to reach the nail and nail bed, circumventing the risk of systemic exposure typically associated with oral terbinafine treatment.

Which Key Players Are Driving Competition In The Onychomycosis Treatment Market?

Major companies operating in the onychomycosis treatment market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Ltd., Sun Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Intas Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Alkem Laboratories Limited, Jubilant Life Sciences Ltd., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Biocon Limited, Emcure Pharmaceuticals Limited, Alembic Pharmaceuticals Ltd., Laurus Labs Limited, Strides Pharma Science Limited, Aarti Drugs Ltd., NATCO Pharma Ltd., Unichem Laboratories Ltd., Indoco Remedies Ltd., Apex Laboratories Pvt. Ltd., Wockhardt Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report

Which Region Currently Holds The Largest Share Of The Onychomycosis Treatment Market?

North America was the largest region in the onychomycosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onychomycosis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Onychomycosis Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12941&type=smp

Browse Through More Reports Similar to the Global Onychomycosis Treatment Market 2026, By The Business Research Company

Aspergillosis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/aspergillosis-treatment-global-market-report

Onychomycosis Market Report 2026

https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report

Yeast Infection Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795